Low-dose-contrast Cardiac Computed Tomography

NCT02146768 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 142

Last updated 2017-06-12

No results posted yet for this study

Summary

Low-dose-contrast CCTA can effectively and safely assess the aortic valve apparatus, and effectively direct the trans-catheter heart valve (THV) size selection by providing accurate annulus sizing, and provide adequate pre-procedural risk-stratification guidance for TAVR/TAVI.

Conditions

  • Aortic Stenosis

Sponsors & Collaborators

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Ambarish Gopal, MD · Baylor Research Institute

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-12-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02146768 on ClinicalTrials.gov